Medical Analysis

Understanding C-Peptide: Essential Marker for Endogenous Insulin Secretion

C-peptide is a critical biological peptide composed of 31 amino acids [3, 7]. It is released from the pancreatic beta cells, where proinsulin is cleaved into insulin and C-peptide in equal amounts [7]. This substance is primarily excreted by the kidney, and its half-life is 3 to 4 times longer than that of insulin [1, 2]. C-peptide molecules bind with peripheral insulin receptors to promote glucose uptake and initiate specific hepatic actions, such as glucose uptake and gluconeogenesis [6]. Known as connecting peptide, it connects the alpha and beta chains of proinsulin, which are formed in the endoplasmic reticulum following the removal of the signal peptide of pre-proinsulin [3, 7].

Advanced Functions and Biological Roles of C-Peptide

C-peptide is far more than a mere byproduct of insulin synthesis; it serves as a multifaceted hormone [3, 6]. Its primary functions include:

• It facilitates insulin production through proinsulin conversion [3].

• It serves as a vital marker for endogenous insulin secretion [1, 2].

• It is an essential tool for assessing pancreatic function during diabetic management [1, 2].

• It contributes to the improvement of nerve function [5, 6].

• It plays a role in vasodilation and blood flow regulation [5, 6].

• It offers protection against various diabetic complications [5, 6].

• As a peptide hormone, it controls energy homeostasis and metabolism [6].

• It helps control appetite, the functions of the gastrointestinal and cardiovascular systems, energy expenditure, and reproduction [6].

Comprehensive Actions of C-Peptide in Human Metabolism

C-peptide exhibits significant physiological influence through several pathways:

• Nitric oxide production: C-peptide enhances microvascular blood flow and improves microvascular endothelial function [5, 6]. It increases microvascular blood flow and mitigates vascular permeability by activating eNOS [5].

• Systemic impact: C-peptide plays an important role in diabetic complications, the reproductive endocrine system, the blood system, tissue repair, tumor diseases, and other aspects [6].

Mechanism of Action of C-Peptide: Signaling and Protection

The biological impact of C-peptide is governed by several refined mechanisms:

• Receptor Binding: C-peptide binds to specific G-protein-coupled receptors (GPCRs) on cell membranes, particularly endothelial, renal, and nerve cells [5, 6].

• Intracellular Signaling: It activates intracellular signaling pathways, mainly MAPK, PI3K-Akt, and Na+/K+-ATPase systems [5, 6].

• Nitric Oxide (NO) Production: By stimulating endothelial nitric oxide synthase (eNOS), it increases NO, which improves microvascular blood flow [5, 6].

• Anti-inflammatory and Antioxidant Effects: C-peptide acts to reduce oxidative stress and pro-inflammatory cytokines [6].

• Cellular Protection: It enhances microvascular function, nerve function, and renal tubular cell survival [5, 6].

• Metabolic Effects: It improves glucose utilization and insulin sensitivity in peripheral tissues [6, 12].

Clinical Indications for C-Peptide Testing

Physicians utilize C-peptide testing for several diagnostic and monitoring purposes, including:

• Assessing hypoglycemic symptoms such as sweating, palpitations, hunger, confusion, blurred vision, and fainting [1, 2].

• Monitoring type 1 and type 2 diabetes mellitus [1, 2].

• The evaluation of insulinoma [1, 8].

• Assessing patients undergoing insulin therapy [1, 2].

• Determining whether the pancreas is producing adequate endogenous insulin [2, 11].

Methods of Laboratory Estimation

C-peptide concentrations are measured using specialized immunological techniques:

• Radioimmunoassay (RIA) [7, 8].

• Enzyme-linked immunosorbent assay (ELISA) [1, 2].

Best Practices for Sample Collection

Proper handling is essential for reliable results:

• Before Sample Collection: Plasma C-peptide levels can be measured in a random, fasting (8 to 10 hours), or stimulated state [2]. Random non-fasting sampling (rCP) is the easiest method and has been shown to correlate with 90-minute mixed meal tolerance test (MMTT) C-peptide responses [1, 2].

• Blood Sample Collection: Collect 3.0 ml of blood in a plain tube (Red capped). Separate serum as early as possible and send it to the laboratory in a frozen state [13].

• Urinary Testing: The 24-hour urinary C-peptide excretion (UCPR) is a useful means of estimating total daily insulin secretion [1, 2].

Reference Ranges for Serum C-Peptide

Oral Glucose Tolerance Test (OGTT) for C-Peptide

After collecting the first fasting sample, the patient is given an oral glucose load of 1.25 gms/kg of body weight [13]. Further half-hourly samples are collected until 3 hours post-ingestion. All samples are subjected to blood glucose, insulin, and C-peptide estimations [13]. In healthy individuals, the plasma concentration of C-peptide in the fasting state is 0.9-1.8 ng/ml, with a postprandial increase to 3.0-9.0 ng/ml [13]. Half of all insulin secreted by the pancreas is metabolized in the liver by first-pass metabolism, whereas C-peptide has negligible hepatic clearance [1, 13].

OGTT Reference Table

Clinical Calculations: C-Peptide Index (CPI)

The C-Peptide Index is calculated using the formula: 100 × serum C-peptide level (ng/mL) / plasma glucose level (mg/dL) [12, 13]. Total C-peptide release was calculated using the ratio of total C-peptide AUC and total glucose AUC during 0-180 min of the OGTT (C-pepAUC180/GluAUC180) [12, 13]. The CPI is widely used to assess endogenous insulin secretary reserves in both type 1 and type 2 diabetes [11, 12].

Etiology of Abnormal Serum C-Peptide Levels

Causes of High Serum C-Peptide: Primary endogenous insulin secretion: Insulinoma, sulfonylurea intoxication [1, 8]. Secondary endogenous causes: Insulin resistance, obesity, glucose intolerance, early type 2 diabetes mellitus [2, 11]. Hyper secretion of insulin-antagonistic hormones: Cushing’s syndrome, Acromegaly [13]. Other: Kidney failure [1, 6].

Causes of Low Serum C-Peptide: Type 1 Diabetes mellitus [1, 15]. Pancreatitis [13]. Pancreatic surgery [13]. Autoimmune disease [15].

Clinical Utility and Comparative Analysis

Clinical Utility Summary

C-Peptide vs. Insulin: Key Differences

For Non-Medicos

What is C-Peptide?

Think of C-peptide as a “tag-along” molecule [3, 8]. When your pancreas creates insulin to manage your blood sugar, it produces insulin and C-peptide in exact equal amounts [7]. Because insulin is used quickly by your body, it is hard to measure accurately [1]. C-peptide lasts longer in your blood, making it a much better, more stable “proxy” or marker for how much insulin your own pancreas is actually producing [2, 11].

Why Do You Need a C-Peptide Test?

Doctors use this test to see if your pancreas is working correctly [1, 2]. It is commonly used to:

• Distinguish between Type 1 and Type 2 diabetes [1, 2].

• Check if you need to start insulin injections [2].

• Find the cause of low blood sugar (hypoglycemia) [1, 13].

• Assess how well a pancreas transplant or islet cell treatment is working [11].

How is the Test Performed?

It is a simple blood test [2]. Sometimes, your doctor might ask you to fast for 8–10 hours before the test [2]. In other cases, they might perform an “Oral Glucose Tolerance Test,” where you drink a sugary liquid, and they test your blood at intervals [13].

Understanding Your Results

• High Levels: This often suggests your body is making too much insulin, which can happen in early Type 2 diabetes due to “insulin resistance” or other conditions [2, 12].

• Low Levels: This suggests your pancreas is not making enough insulin, which is common in Type 1 diabetes or after certain pancreatic surgeries [1, 13].

References:

1. Jones, A. G., & Hattersley, A. T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30(7), 803–817. https://doi.org/10.1111/dme.12159

2. Leighton, E., Sainsbury, C. A. R., & Jones, G. C. (2017). A practical review of C-peptide testing in diabetes. Diabetes Therapy, 8(3), 475–487. https://doi.org/10.1007/s13300-017-0265-4

3. Steiner, D. F. (2004). The proinsulin C-peptide—a multirole model. Experimental Diabesity Research, 5(1), 7–14. https://doi.org/10.1080/15438600490424389

4. Rickels, M. R., et al. (2020). High residual C-peptide likely contributes to glycemic control in type 1 diabetes. Journal of Clinical Investigation, 130(11), 6006–6017. https://doi.org/10.1172/JCI134057

5. Wahren, J., Kallas, Å., & Sima, A. A. (2012). The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes, 61(4), 761–772. https://doi.org/10.2337/db11-1375

6. Chen, J., Huang, Y., Liu, C., Chi, J., Wang, Y., & Xu, L. (2023). The role of C-peptide in diabetes and its complications: an updated review. Frontiers in Endocrinology, 14, 1256093. https://doi.org/10.3389/fendo.2023.1256093

7. Steiner, D. F., & Oyer, P. E. (1967). The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proceedings of the National Academy of Sciences, 57(2), 473–480. https://doi.org/10.1073/pnas.57.2.473

8. Brandenburg, D. (2008). History and diagnostic significance of C-peptide. Journal of Diabetes Research, 2008, 576862. https://doi.org/10.1155/2008/576862

9. Patel, N., Taveira, T. H., Choudhary, G., Whitlatch, H., & Wu, W. C. (2012). Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. Journal of the American Heart Association, 1(6), e003152. https://doi.org/10.1161/JAHA.112.003152

10. Li, Y., Li, Y., Meng, L., & Zheng, L. (2015). Association between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals. PLOS ONE, 10(1), e112281. https://doi.org/10.1371/journal.pone.0112281

11. Briggs, L., & Jones, A. G. (2024). The evolution of C-peptide’s role in diabetes care. Diabetic Medicine, 41(7), e15316. https://doi.org/10.1111/dme.15316

12. Vinay, E. S., & Bansal, S. (2024). C-peptide in precision diabetes care and beyond: a comprehensive review. Journal of Clinical and Translational Endocrinology, 34, 100366. https://doi.org/10.1016/j.jcte.2024.100366

13. Sacks, D. B. (2023). Diabetes mellitus. In N. Rifai, R. W. K. Chiu, I. Young, C.-A. D. Burnham, & C. T. Wittwer (Eds.), Tietz Textbook of Laboratory Medicine (7th ed., chap 47). Elsevier.

14. Dhatariya, K. K., Umpierrez, G. E., & Crandall, J. P. (2024). Diabetes mellitus. In L. Goldman & K. A. Cooney (Eds.), Goldman-Cecil Medicine (27th ed., chap 210). Elsevier.

15. Atkinson, M. A., McGill, D. E., Dassau, E., & Laffel, L. (2020). Type 1 diabetes mellitus. In S. Melmed, R. J. Auchus, A. B. Goldfine, R. J. Koenig, & C. J. Rosen (Eds.), Williams Textbook of Endocrinology (14th ed., chap 36). Elsevier.

FAQ’s:

• What is C-peptide?
  C-peptide is a 31-amino acid protein released by pancreatic beta cells alongside insulin production.

• Why test C-peptide levels? It helps assess pancreatic function and determine if your body is producing its own insulin.

• How is C-peptide produced?
  It is produced when proinsulin is cleaved into equal amounts of insulin and C-peptide.

• Does C-peptide impact nerves?
  Yes, C-peptide improves nerve function and protects against various diabetic complications.

• Is fasting required for testing?
  Testing can be done randomly, though fasting (8–10 hours) is also a standard method.

• How is the sample collected?
  Blood is collected in a plain red-capped tube and must be sent to the lab frozen.

• What does low C-peptide mean?
  Low levels suggest the pancreas is not producing enough insulin, often seen in Type 1 diabetes.

• What causes high C-peptide?
  High levels result from insulin resistance, obesity, or conditions like insulinoma and early Type 2 diabetes.

• Does insulin therapy affect results?
  No, C-peptide levels are not affected by exogenous insulin therapy, unlike direct insulin measurements.

• How is C-peptide measured?
  It is typically measured in laboratories using Radioimmunoassay (RIA) or Enzyme-linked immunosorbent assay (ELISA).

Related Diagnostic Tests

• Insulin

• Glucose

• HbA1c